Logo image of RVP

RETRACTABLE TECHNOLOGIES INC (RVP) Stock Fundamental Analysis

USA - NYSEARCA:RVP - US76129W1053 - Common Stock

0.9747 USD
-0.06 (-5.37%)
Last: 10/10/2025, 8:56:16 PM
Fundamental Rating

2

Taking everything into account, RVP scores 2 out of 10 in our fundamental rating. RVP was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While RVP seems to be doing ok healthwise, there are quite some concerns on its profitability. RVP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RVP had negative earnings in the past year.
In the past year RVP has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: RVP reported negative net income in multiple years.
RVP had a positive operating cash flow in 4 of the past 5 years.
RVP Yearly Net Income VS EBIT VS OCF VS FCFRVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of RVP (-6.10%) is better than 65.44% of its industry peers.
RVP has a better Return On Equity (-11.73%) than 65.44% of its industry peers.
Industry RankSector Rank
ROA -6.1%
ROE -11.73%
ROIC N/A
ROA(3y)-3.04%
ROA(5y)8.65%
ROE(3y)-5.56%
ROE(5y)18.57%
ROIC(3y)N/A
ROIC(5y)N/A
RVP Yearly ROA, ROE, ROICRVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

RVP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVP Yearly Profit, Operating, Gross MarginsRVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

RVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RVP remains at a similar level compared to 1 year ago.
RVP has less shares outstanding than it did 5 years ago.
RVP has a better debt/assets ratio than last year.
RVP Yearly Shares OutstandingRVP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
RVP Yearly Total Debt VS Total AssetsRVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

RVP has an Altman-Z score of 0.60. This is a bad value and indicates that RVP is not financially healthy and even has some risk of bankruptcy.
RVP's Altman-Z score of 0.60 is in line compared to the rest of the industry. RVP outperforms 47.12% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that RVP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, RVP is in the better half of the industry, outperforming 71.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACC8.61%
RVP Yearly LT Debt VS Equity VS FCFRVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 7.01 indicates that RVP has no problem at all paying its short term obligations.
RVP has a better Current ratio (7.01) than 85.86% of its industry peers.
A Quick Ratio of 4.73 indicates that RVP has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.73, RVP belongs to the top of the industry, outperforming 81.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.01
Quick Ratio 4.73
RVP Yearly Current Assets VS Current LiabilitesRVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.63% over the past year.
The Revenue has decreased by -0.25% in the past year.
RVP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.59% yearly.
EPS 1Y (TTM)50.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.97%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y-44.02%
Revenue growth 5Y-4.59%
Sales Q2Q%73.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RVP Yearly Revenue VS EstimatesRVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVP Price Earnings VS Forward Price EarningsRVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVP Per share dataRVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RVP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RETRACTABLE TECHNOLOGIES INC

NYSEARCA:RVP (10/10/2025, 8:56:16 PM)

0.9747

-0.06 (-5.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-12 2025-11-12
Inst Owners6.98%
Inst Owner Change0%
Ins Owners57.4%
Ins Owner Change3.03%
Market Cap29.18M
Analysts0
Price TargetN/A
Short Float %0.3%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)2.82%
DP-2.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.38
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS1.27
BVpS2.55
TBVpS2.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.1%
ROE -11.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.04%
ROA(5y)8.65%
ROE(3y)-5.56%
ROE(5y)18.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.02%
Cap/Sales 3.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.01
Quick Ratio 4.73
Altman-Z 0.6
F-Score3
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)132.07%
Cap/Depr(5y)1512.98%
Cap/Sales(3y)8.02%
Cap/Sales(5y)16.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y-44.02%
Revenue growth 5Y-4.59%
Sales Q2Q%73.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-287.18%
OCF growth 3YN/A
OCF growth 5YN/A